Roche, Aileron to expand collaboration to develop stapled peptide drugs
The companies entered the $1.1bn collaboration agreement in August 2010, which covers five programs. Under the collaboration, the two key programs were pertaining to oncology and the third
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.